Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial

Tropical Medicine and International Health

Volumn 21, Issue 2, 2016, Pages 224-235

  Tagbor, Harry ^a,b   Antwi, Gifty Dufie ^b   Acheampong, Princess Ruhama ^b   Bart Plange, Constance ^c   Chandramohan, Daniel ^d   Cairns, Matthew ^d  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b Centre for Global Health Research   (Ghana)

^c GHANA HEALTH SERVICE   (Ghana)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

artemisinin based combination therapies; Ashanti; community case management; Ghana; individually randomised; placebo controlled trial; seasonal malaria chemoprevention

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE; PLACEBO; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL AGENT; COMMUNITY HEALTH WORKER; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG PRESCRIBING; HEALTH IMPACT; MALARIA; PUBLIC HEALTH;

ARTICLE; CASE MANAGEMENT; CHEMOPROPHYLAXIS; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GHANA; HAZARD RATIO; HEALTH AUXILIARY; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; RANDOMIZED CONTROLLED TRIAL; SEASON;

ASHANTI; GHANA;

EID: 84978966770     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12642     Document Type: Article

References (27)

1. Wilson AL. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE 2011: 6: e16976.
2. World Health Organisation. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa, 2012. [Available from: http://www.who.int/malaria/publications/atoz/who_smc_policy_recommendation/en/] [cited 2014 28th May].
3. Cisse B, Cairns M, Faye E et al. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS ONE 2009: 4: e7164.
4. Cisse B, Sokhna C, Boulanger D et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 2006: 367: 659–667.
5. Sokhna C, Cisse B, Ba EH et al. A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children. PLoS ONE 2008: 3: e1471.
6. Konate AT, Yaro JB, Ouedraogo AZ et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med 2011: 8: e1000408.
7. Dicko A, Diallo AI, Tembine I et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med 2011: 8: e1000407.
8. Cairns M, Roca-Feltrer A, Garske T et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun 2012: 3: 881.
9. Adjuik M, Bagoyoko M, Binka F et al. Towards an Atlas of Malaria Risk in Africa (MARA/ARMA Collaboration), 1998.
10. Kweku M, Liu D, Adjuik M et al. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS ONE 2008: 3: e4000.
11. Ndiaye J, Ndiaye Y, Ba M et al. Seasonal malaria chemoprevention and community case-management for malaria in Southern Senegal: a cluster-randomized trial, Atlanta, Georgia, USA, 2012.
12. Arinaitwe E, Sandison TG, Wanzira H et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis 2009: 49: 1629–1637.
13. The Four Artemisinin-Based Combinations (4ABC) Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med 2011: 8: e1001119.
14. Okell LC, Cairns M, Griffin JT et al. Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun 2014: 5: 5606.
15. Cairns M, Walker PGT, Okell LC et al. Seasonality in malaria transmission - implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa. Malaria Journal 2015: 14: 321.
16. Tagbor H, Cairns M, Nakwa E et al. The clinical impact of combining intermittent preventive treatment with home management of malaria in children aged below 5 years: cluster randomised trial. Trop Med Int Health 2010: 16: 280–289.
17. Kobbe R, Kreuzberg C, Adjei S et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007: 45: 16–25.
18. Cheung YB, Xu Y, Tan SH, Cutts F, Milligan P. Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined. Stat Med 2010: 29: 328–336.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004: 159: 702–706.
20. Druetz T, Fregonese F, Bado A et al. Abolishing Fees at Health Centers in the Context of Community Case Management of Malaria: What Effects on Treatment-Seeking Practices for Febrile Children in Rural Burkina Faso? PLoS ONE 2015: 10: e0141306. doi:10.1371/journal.pone.0141306.
21. Ezeoke OP, Ezumah NN, Chandler CC et al. Exploring health providers’ and community perceptions and experiences with malaria tests in South-East Nigeria: a critical step towards appropriate treatment. Malar J 2012: 11: 368.
22. Thomson R, Festo C, Johanes B et al. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria. PLoS ONE 2014: 9: e95607.
23. Bigira V, Kapisi J, Clark TD et al. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young ugandan children: a randomized controlled trial. PLoS Med 2014: 11: e1001689.
24. Flegg JA, Patil AP, Venkatesan M et al. Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J 2013: 12: 249.
25. Coulibaly SO, Kayentao K, Taylor S et al. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J 2014: 13: 41.
26. Bojang KA, Akor F, Conteh L et al. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med 2011: 8: e1000409.
27. Ward A, Graves JC, Omoniwa OF et al. Comparison of seasonal malaria chemoprevention coverage in Northern Nigeria via door-to-door, health facility and retail sector delivery. American Society of Tropical Medicine and Hygiene Annual Meeting: New Orleans, Louisiana, USA, 2014.